The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
INTERACTION OF ANTIGENS AND ANTIBODIES AT MUCOSAL SURFACES
Abstract
▪ Abstract Infections often involve the mucosal surfaces of the body, which form a boundary with the outside world. This review focuses on immunoglobulin A (IgA) antibodies because IgA is the principal mucosal antibody class. IgA is synthesized by local plasma cells and has a specific polymeric immunoglobulin receptor-mediated transport mechanism for entry into the secretions. By serving as an external barrier capable of inhibiting attachment of microbes to the luminal surface of the mucosal epithelial lining, IgA antibodies form the first line of immune defense. In addition to this traditional mode of extracellular antibody function, recent evidence suggests that IgA antibodies can also function in a nontraditional fashion by neutralizing viruses intracellularly, if a virus is infecting an epithelial cell through which specific IgA antibody is passing on its way to the secretions. IgA antibodies are also envisaged as providing an internal mucosal barrier beneath the mucosal lining. Antigens intercepted by IgA antibodies here can potentially be ferried through the epithelium and thereby excreted. In addition to the polymeric immunoglobulin receptor on mucosal epithelial cells, IgA antibodies can bind to receptors on a variety of leukocytes and have been shown, in some experimental systems, to be capable of activating the alternative complement pathway, making IgA antibodies potential participants in inflammatory reactions. Although the relationship of IgA antibodies to inflammation is not entirely clear, the bias presented is that IgA is basically noninflammatory, perhaps even anti-inflammatory. According to this view, the major role of the Fc portion of IgA antibodies is to transport IgA across mucosal epithelial cells and not, as in the case of the other classes of antibody, to activate secondary phenomena of the kind that contribute to inflammation. Because of IgA's key role as an initial barrier to infection, much current research in mucosal immunology is directed toward developing new vectors and adjuvants that can provide improved approaches to mucosal vaccines. Finally, because of advances in monoclonal antibody technology, topical application of antibodies to mucosal surfaces has significant potential for preventing and treating infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Making antibodies by phage display technology
Winter, G., Griffiths, A. D., Hawkins, R. E., & Hoogenboom, H. R. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.002245 · Cited by 1,573
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations.
Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C., & Robinson, H. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11478 · Cited by 1,115
Weiner, H. L. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.809 · Cited by 906
The mucosal immune system: from fundamental concepts to vaccine development
McGhee, J. R., Mestecky, J., Dertzbaugh, M. T., Eldridge, J. H., Hirasawa, M., & Kiyono, H. (1992) · Vaccine · doi:10.1016/0264-410x(92)90021-b · Cited by 903
Inhibition of Bacterial Adherence by Secretory Immunoglobulin A: A Mechanism of Antigen Disposal
Williams, R. C., & Gibbons, R. J. (1972) · Science · doi:10.1126/science.177.4050.697 · Cited by 753
McDermott, M. R., & Bienenstock, J. (1979) · PubMed · Cited by 733
Handbook of Mucosal Immunology
(1994) · Elsevier eBooks · doi:10.1016/c2009-1-03796-4 · Cited by 706
Defrance, T., Vanbervliet, B., Brière, F., Durand, I., Rousset, F., & Banchereau, J. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.3.671 · Cited by 638
Generation and Assembly of Secretory Antibodies in Plants
Ma, J. K.-C., Hiatt, A., Hein, M., Vine, N. D., Wang, F., Stabila, P., van Dolleweerd, C., Mostov, K., & Lehner, T. (1995) · Science · doi:10.1126/science.7732380 · Cited by 612
The structure and function of human IgA
Kerr, M. A. (1990) · Biochemical Journal · doi:10.1042/bj2710285 · Cited by 596
Cited by
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
Hogg, J. C., Chu, F., Utokaparch, S., Woods, R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032158 · Cited by 3,782
Cross-presentation by dendritic cells
Joffre, O. P., Segura, E., Savina, A., & Amigorena, S. (2012) · Nature Reviews Immunology · doi:10.1038/nri3254 · Cited by 1,637
The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins
Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141702 · Cited by 1,307
Pathophysiology of airflow limitation in chronic obstructive pulmonary disease
Hogg, J. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16900-6 · Cited by 1,294
Mucosal vaccines: the promise and the challenge
Neutra, M. R., & Kozlowski, P. A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1777 · Cited by 1,223
Chieppa, M., Rescigno, M., Huang, A. Y. C., & Germain, R. N. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061884 · Cited by 713
Transcytosis: Crossing Cellular Barriers
TUMA, P. L., & HUBBARD, A. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00001.2003 · Cited by 681
Kaetzel, C. S. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00278.x · Cited by 582
Collaboration of epithelial cells with organized mucosal lymphoid tissues
Neutra, M. R., Mantis, N. J., & Kraehenbuhl, J.-P. (2001) · Nature Immunology · doi:10.1038/ni1101-1004 · Cited by 579
Natural antibodies and complement link innate and acquired immunity
Ochsenbein, A. F., & Zinkernagel, R. M. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01754-0 · Cited by 537
Teleost skin, an ancient mucosal surface that elicits gut-like immune responses
Xu, Z., Parra, D., Gómez, D., Salinas, I., Zhang, Y.-A., von Gersdorff Jørgensen, L., Heinecke, R. D., Buchmann, K., LaPatra, S., & Sunyer, J. O. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304319110 · Cited by 521
Serum IgA, IgM, and IgG responses in COVID-19
Ma, H., Zeng, W., He, H., Zhao, D., Jiang, D., Zhou, P., Cheng, L., Li, Y., Ma, X., & Jin, T. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0474-z · Cited by 511
Secretory IgA N- and O-Glycans Provide a Link between the Innate and Adaptive Immune Systems
Royle, L., Roos, A., Harvey, D. J., Wormald, M. R., Van Gijlswijk-Janssen, D., Redwan, E.-R. M., Wilson, I. A., Daha, M. R., Dwek, R. A., & Rudd, P. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301436200 · Cited by 335
Huber, V. C., Lynch, J. M., Bucher, D. J., Le, J., & Metzger, D. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7381 · Cited by 319
Maternal IgG and IgA Antibodies Dampen Mucosal T Helper Cell Responses in Early Life
Koch, M. A., Reiner, G. L., Lugo, K. A., Kreuk, L. S. M., Stanbery, A. G., Ansaldo, E., Seher, T. D., Ludington, W. B., & Barton, G. M. (2016) · Cell · doi:10.1016/j.cell.2016.04.055 · Cited by 315
Immunoglobulin transport across polarized epithelial cells
Rojas, R., & Apodaca, G. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm972 · Cited by 309
Salivary IgA as a Risk Factor for Upper Respiratory Infections in Elite Professional Athletes
NEVILLE, V., GLEESON, M., & FOLLAND, J. P. (2008) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31816be9c3 · Cited by 298
Cohen, S., Miller, G. E., & Rabin, B. S. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200101000-00002 · Cited by 286
Nanoparticles for nasal vaccination
Csaba, N., Garcia-Fuentes, M., & Alonso, M. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.005 · Cited by 277
Lactic Acid Bacteria As Live Vaccines
(2000) · Current Issues in Molecular Biology · doi:10.21775/cimb.002.017 · Cited by 193
Metadata
- Authors
- Lamm, M. E.
- Venue
- Annual Review of Microbiology
- Publisher
- Annual Reviews
- Published
- 1997-10
- Volume
- 51
- Issue
- 1
- Pages
- 311-340
- ISSN
- 0066-4227 (ISSN-L)
- 1545-3251
- OpenAlex
- W2145380311
- Cited by
- 429
- References
- 117
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.